Fresenius Medical Cuts 2026 Profit Outlook as US Treatments Fall
Direct answer
Fresenius Medical Care cut the top end of its 2026 profit outlook on November 3, 2026, because fewer dialysis treatments in the United States are weighing on its business. The German dialysis company still beat profit expectations for the third quarter, but it now expects full year operating income to range from flat to a mid single digit percentage fall.
What happened
Fresenius Medical Care, known as FMC, provides dialysis treatment for people whose kidneys no longer work well enough on their own. In the third quarter of 2026, its operating income excluding special items fell 5 percent to 545 million euros, down from 574 million euros a year earlier. That result was above the 518 million euros expected in a Vara Research consensus, according to Reuters. Revenue grew 1 percent to 4.94 billion euros, up from 4.89 billion euros a year earlier.
The main problem was in the United States, which accounts for more than half of the company’s revenue. Same market treatments there fell 1.1 percent in the third quarter. That followed falls of 0.4 percent in the first quarter and 0.9 percent in the second quarter, so the decline is getting larger, not smaller. Reuters reported that regulatory and inflation pressures also weighed on the results.
The company also recorded 108 million euros in one off costs linked to a change of strategy in China, including stopping a dialysis system and leaving peritoneal dialysis there. FMC now expects 2026 operating income to range from flat to a mid single digit percentage decline. Its earlier forecast ranged from a mid single digit percentage decline to a mid single digit percentage increase, so the change removes the best case outcome. Shares fell 4 percent shortly after trading opened, then recovered to trade 1 percent higher by 0945 GMT, Reuters reported.
Why it matters for beginners
A profit outlook is a company’s own guide to how much profit it expects to make. When a company cuts the top end of that guide, it is telling investors that the best outcome it once saw is no longer likely, even if the latest quarter was better than feared. That is why a share price can fall at first even after a result beats expectations.
For beginners, the lesson is to look past one headline number. FMC beat the profit forecast, but the trend in US treatments mattered more, because the United States is its largest market. A single quarter can look fine while the direction underneath is still getting worse. A related example is Bayer, which raised its profit outlook in the same earnings season, showing that results can move in different directions even in the same broad health care sector.
What to watch next
Watch whether US treatment volumes stop falling in the fourth quarter, and whether the new chief executive, Shervin J. Korangy, sets out a clearer plan to return the largest market to growth. Also watch the next full year update for any change to the new operating income range, and for progress on costs after the China strategy change.
FAQ
What does Fresenius Medical Care do?
It is a German company that provides dialysis care and related products for people with kidney failure.
Why did it cut its 2026 outlook?
It cut the top end of its operating income outlook after US same market treatments fell 1.1 percent in the third quarter, the third quarterly fall in a row.
Did the third quarter beat expectations?
Yes, on the measure excluding special items. Operating income of 545 million euros was above the Vara Research consensus of 518 million euros, even though it was 5 percent lower than a year earlier.
What is operating income?
It is profit from the company’s main business activities, before interest and tax. FMC reported this figure excluding special items, which removes one off costs so the underlying trend is easier to see.
